Trial Profile
Research on the preventive effect of the atrial fibrillation by febuxostat
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2014
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Atrial fibrillation; Hyperuricaemia
- Focus Therapeutic Use
- 09 Jun 2014 New trial record